Financial Architects (New Jersey)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-282
| Closed | -$1K | – | 1407 |
|
|
2018
Q3 | $1K | Hold |
282
| – | – | ﹤0.01% | 1256 |
|
|
2018
Q2 | $1K | Hold |
282
| – | – | ﹤0.01% | 1309 |
|
|
2018
Q1 | $1K | Hold |
282
| – | – | ﹤0.01% | 1237 |
|
|
2017
Q4 | $1K | Hold |
282
| – | – | ﹤0.01% | 1332 |
|
|
2017
Q3 | $2K | Hold |
282
| – | – | ﹤0.01% | 1337 |
|
|
2017
Q2 | $2K | Hold |
282
| – | – | ﹤0.01% | 1348 |
|
|
2017
Q1 | $2K | Hold |
282
| – | – | ﹤0.01% | 1387 |
|
|
2016
Q4 | $2K | Hold |
282
| – | – | ﹤0.01% | 1296 |
|
|
2016
Q3 | $1K | Hold |
282
| – | – | ﹤0.01% | 1384 |
|
|
2016
Q2 | $2K | Buy |
+282
| New | +$2K | ﹤0.01% | 1325 |
|
|
2015
Q3 | – | Sell |
-127
| Closed | -$1K | – | 1060 |
|
|
2015
Q2 | $1K | Buy |
+127
| New | +$1K | ﹤0.01% | 1157 |
|